checkAd
    Startseite > Aktien > Caribou Biosciences > Nachrichten
    Caribou Biosciences Aktie
    2,9700
     
    USD
    -1,33 %
    -0,0400 USD
    Letzter Kurs 25.05.24 Nasdaq
    2,9700
     
    USD
    19.400 STK
    Geldkurs 24.05.24
    2,9800
     
    USD
    3.800 STK
    Briefkurs 24.05.24
    ISIN: US1420381089 · WKN: A3CVT6 · SYM: CRBU · USA

    Neueste Nachrichten

    Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
    07.05.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences to Participate in Upcoming Investor Conferences
    01.05.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    24.04.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
    15.04.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
    04.04.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    11.03.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
    05.03.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences to Participate in Upcoming Investor Conferences
    15.02.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
    07.01.24 · globenewswire · Caribou Biosciences
    Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
    07.11.23 · globenewswire · Caribou Biosciences
    Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board
    06.11.23 · globenewswire · Caribou Biosciences
    Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
    18.10.23 · globenewswire · Caribou Biosciences